Document:

Exhibit 10.1

 

FIRST AMENDMENT

TO THE

MEDICALCV, INC.

AMENDED AND RESTATED 2001 EQUITY INCENTIVE PLAN

 

In accordance with Section 11
of the Amended and Restated 2001 Equity Incentive Plan (the “Plan”), which
permits the Board to amend the Plan, the Plan is hereby amended effective as of
February 15, 2008.  Section 1.3
shall be amended and restated as follows:

 

“1.3         Change in Control.   The term “Change in Control” shall mean:

 

(a)          the acquisition by any person or group
deemed a person under Sections 3(a)(9) and 13(d)(3) of the Exchange
Act (other than the Company and its subsidiaries as determined immediately
prior to that date) of beneficial ownership, directly or indirectly (with
beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;

 

(b)          the date of approval by the
shareholders of the Company of an agreement providing for the merger or
consolidation of the Company with another corporation or other entity where (x) shareholders
of the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to such
merger or consolidation, would not, immediately after such merger or
consolidation, constitute a majority of the board of directors of the surviving
corporation; or

 

(c)          the sale of all or substantially all
of the assets of the Company.”

 

 

Dated:  February 22, 2008

 

	
   

  	
  MEDICALCV, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  Michael A. Brodeur

  
	
   

  	
  Its:

  	
  Vice President, Finance and Chief Financial
  OfficerExhibit 10.2

 

FIRST AMENDMENT

TO THE

MEDICALCV, INC.

AMENDED AND RESTATED 2005 DIRECTOR STOCK OPTION PLAN

 

In accordance with Section 8
of the Amended and Restated Director Stock Option Plan (the “Plan”), which
permits the Board to amend the Plan, the Plan is hereby amended effective as of
February 15, 2008.  Section 6(d) shall
be amended and restated as follows:

 

“(d) “Change of
Control” means any one of the following:

 

(i)         the acquisition by any person or group
deemed a person under Sections 3(a)(9) and 13(d)(3) of the Exchange
Act (other than the Company and its subsidiaries as determined immediately
prior to that date) of beneficial ownership, directly or indirectly (with
beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;

 

(ii)        the date of approval by the shareholders
of the Company of an agreement providing for the merger or consolidation of the
Company with another corporation or other entity where (x) shareholders of
the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to
such merger or consolidation, would not, immediately after such merger or
consolidation, constitute a majority of the board of directors of the surviving
corporation; or

 

(iii)       the sale of all or substantially all of
the assets of the Company.”

 

Dated:  February 22, 2008

 

	
   

  	
  MEDICALCV, INC.

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  Michael A. Brodeur

  
	
   

  	
  Its:

  	
  Vice President, Finance and Chief Financial
  OfficerExhibit 10.3

 

FIRST AMENDMENT

TO THE

MEDICALCV, INC.

MANAGEMENT INCENTIVE PLAN

 

Effective as of February 15,
2008, the Management Incentive Plan (“MIP”) shall be amended to read as
follows:

 

1.          The following shall be added to the Section titled,
“Payment in the Event of a Change in Control”:

 

“For purposes of this Plan, change in control shall mean:

 

(a)           the acquisition by any person or
group deemed a person under Sections 3(a)(9) and 13(d)(3) of the
Exchange Act (other than the Company and its subsidiaries as determined
immediately prior to that date) of beneficial ownership, directly or indirectly
(with beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;

 

(b)           the date of approval by the
shareholders of the Company of an agreement providing for the merger or
consolidation of the Company with another corporation or other entity where (x) shareholders
of the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to
such merger or consolidation, would not, immediately after such merger or consolidation,
constitute a majority of the board of directors of the surviving corporation;
or

 

(c)           the sale of all or substantially all
of the assets of the Company.”

 

Dated:  February 22, 2008

 

	
   

  	
  MEDICALCV, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  Michael A. Brodeur

  
	
   

  	
  Its:

  	
  Vice President, Finance and Chief Financial
  OfficerExhibit 10.4

 

MEDICALCV, INC.

 

NON-QUALIFIED STOCK OPTION AGREEMENT

PURSUANT TO AMENDED AND RESTATED 2001 EQUITY INCENTIVE
PLAN

 

	
  No. of shares
  subject to option:

  	
   

  	
  Option No.:

  
	
  Date of grant:

  	
   

  	
   

  

 

THIS OPTION AGREEMENT is entered into by and between MedicalCV, Inc.,
a Minnesota corporation (the “Company”), and
                                        
(the “Optionee”) pursuant to the Company’s Amended and Restated 2001 Equity
Incentive Plan (the “Plan”).  Unless
otherwise defined herein, certain capitalized terms shall have the meaning set
forth in the Plan.

 

W I T N E S S E T
H:

 

1.             Nature of the Option.  This Option is not intended to qualify as an
Incentive Stock Option within the meaning of Section 422 of the United
States Internal Revenue Code of 1986, as amended.

 

2.             Grant of Option. 
Pursuant to the provisions of the Plan, the Company grants to the
Optionee, subject to the terms and conditions of the Plan and to the terms and
conditions herein set forth, the right and option to purchase from the Company
all or a part of an aggregate of
                        
(                                  )
shares of Stock (the “Shares”) at the purchase price of
$             per
share, such Option to be exercised as hereinafter provided.  The exercise price is not less than the fair
market value of the stock on the date of the grant.

 

3.             Terms and Conditions.  It is understood and agreed that the Option
evidenced hereby is subject to the following terms and conditions:

 

(a)           Expiration Date.  This Option shall expire ten years after the
date of grant specified above. 
Notwithstanding the foregoing, if the Optionee’s employment or
relationship with the Company or Related Company is terminated by reason of
death, Disability or Retirement, this Option shall expire on the one-year
anniversary of the termination date.  If
the Optionee’s employment or relationship with the Company or Related Company
is terminated by reasons for other than death, Disability or Retirement, this
Option shall, subject to Section 4 of the Plan, expire on the three-month
anniversary of the termination date. 
Except as otherwise provided by the Board, an Optionee shall be
considered to have a “Disability” if the Optionee is unable, by reason of a
medically determinable physical or mental impairment, to substantially perform
the principal duties of employment with the Company, which condition, in the
opinion of a physician selected by the Board, is expected to have a duration of
not less than 120 days.

 

(b)           Exercise
of Option.  Subject to the Plan and the
other terms of this Agreement regarding the exercisability of this Option, this
Option shall be exercisable cumulatively, to the extent it is vested, as set
forth in Exhibit A.  Any exercise
shall be accompanied by a written notice to the Company specifying the number
of shares of Stock as to which the Option is being exercised.  Notation of any partial exercise shall be
made by the Company on Schedule I hereto. 
This Option 

 

 

may not be
exercised for a fraction of a Share, and must be exercised for no fewer than
one hundred (100) shares of Stock, or such lesser number of shares as may be
vested.

 

(c)           Payment
of Purchase Price Upon Exercise.  At
the time of any exercise, the Exercise Price of the Shares as to which this
Option is exercised shall be paid in cash to the Company, unless, in accordance
with the provisions of Section 4.2(c) of the Plan, the Board shall
permit or require payment of the purchase price in another manner set forth in
the Plan.  This Option does not include
any feature for the deferral of compensation following its exercise.

 

(d)           Nontransferability.  This Option shall not be transferable other
than by will or by the laws of descent and distribution.  During the lifetime of the Optionee, this
Option shall be exercisable only by the Optionee or by the Optionee’s guardian
or legal representative.  No transfer of
this Option by the Optionee by will or by the laws of descent and distribution
shall be effective to bind the Company unless the Company is furnished with
written notice thereof and a copy of the will and/or such other evidence as the
Board may determine necessary to establish the validity of the transfer.

 

(e)           Acceleration
of Option Upon Change in Control.  In
the event of a Change in Control, as defined in Section 1.3 of the Plan,
the provisions of Section 3(b) and Exhibit A hereof pertaining
to vesting shall cease to apply and this Option shall become immediately vested
and fully exercisable with respect to all Shares; provided, however, that the
provisions of this Subsection 3(e) shall not apply unless the Optionee has
been employed by the Company for a period equal to or exceeding one calendar
year.  No acceleration of vesting shall
occur under this Subsection 3(e) in the event a surviving corporation or
its parent assumes this Option or in the event the surviving corporation or its
parent substitutes an option agreement with substantially the same terms as
provided in this Agreement.  Nothing in
this Subsection 3(e) shall limit the Committee’s authority to cancel this
Option in accordance with Section 9 of the Plan.

 

(f)            Subject
to Lock Up.  Optionee understands
that the Company at a future date may file a registration or offering statement
(the “Registration Statement”) with the Securities and Exchange Commission to
facilitate an underwritten public offering of its securities.  The Optionee agrees, for the benefit of the
Company, that should such an underwritten public offering be made and should
the managing underwriter of such offering require, the undersigned will not, without
the prior written consent of the Company and such underwriter, during the Lock
Up Period as defined herein: sell, transfer or otherwise dispose of, or agree
to sell, transfer or otherwise dispose of this Option or any of the Shares
acquired upon exercise of this Option during the Lock Up Period; or sell or
grant, or agree to sell or grant, options, rights or warrants with respect to
any of the Shares acquired upon exercise of this Option.  The foregoing does not prohibit gifts to
donees or transfers by will or the laws of descent to heirs or beneficiaries
provided that such donees, heirs and beneficiaries shall be bound by the
restrictions set forth herein.  The term “Lock
Up Period” shall mean the lesser of (x) 180 days or (y) the period
during which Company officers and directors are restricted by the managing
underwriter from effecting any sales or transfers of the Shares.  The Lock Up Period shall commence on the
effective date of the Registration Statement.

 

(g)           Not
An Employment Contract.  The Option
will not confer on the Optionee any right with respect to continuance of
employment or other service with the Company or any Subsidiary, 

 

2

 

nor will it
interfere in any way with any right the Company or any Subsidiary would
otherwise have to terminate or modify the terms of such Optionee’s employment
or other service at any time.

 

(h)           No
Rights as Shareholder.  The Optionee
shall have no rights as a shareholder of the Company with respect to any Shares
prior to the date of issuance to the Optionee of a certificate for such Shares.

 

(i)            Compliance
with Law and Regulations.  This
Option and the obligation of the Company to sell and deliver Shares hereunder
shall be subject to all applicable laws, rules and regulations (including,
but not limited to, federal securities laws) and to such approvals by any
government or regulatory agency as may be required.  This Option shall not be exercisable, and the
Company shall not be required to issue or deliver any certificates for Shares
of Stock prior to the completion of any registration or qualification of such
Shares under any federal or state law, or any rule or regulation of any
government body which the Company shall, in its sole discretion, determine to
be necessary or advisable.  Moreover,
this Option may not be exercised if its exercise or the receipt of Shares of
Stock pursuant thereto would be contrary to applicable law.

 

(j)            Withholding.  All deliveries and distributions under this
Agreement are subject to withholding of all applicable taxes.  The Company is entitled to (a) withhold
and deduct from future wages of the Optionee (or from other amounts that may be
due and owing to the Optionee from the Company), or make other arrangements for
the collection of, all legally required amounts necessary to satisfy any
federal, state or local withholding and employment-related tax requirements
attributable to the Option, or (b) require the Optionee promptly to remit
the amount of such withholding to the Company before acting on the Optionee’s
notice of exercise of this Option.  At
the election of the Optionee, and subject to such rules and limitations as
may be established by the Committee from time to time, such withholding
obligations may be satisfied through the surrender of shares of Stock which the
Optionee already owns, or to which the Optionee is otherwise entitled under the
Plan.

 

4.             Termination
of Employment.  Upon the termination
of the employment of Optionee prior to the expiration of the Option, the following
provisions shall apply:

 

(a)           Upon
the Involuntary Termination of Optionee’s employment or the voluntary
termination or resignation of Optionee’s employment, the Optionee may exercise
the Option to the extent the Optionee was vested in and entitled to exercise
the Option at the date of such employment termination for a period of three (3) months
after the date of such employment termination, or until the term of the Option
has expired, whichever date is earlier. 
To the extent the Optionee was not entitled to exercise this Option at
the date of such employment termination, or if Optionee does not exercise this
Option within the time specified herein, this Option shall terminate.

 

(b)           If
the employment of an Optionee is terminated by the Company for cause, then the
Board or the Committee shall have the right to cancel the Option.

 

5.             Death,
Disability or Retirement of Optionee. 
Upon the death, Disability or Retirement, as defined herein, of Optionee
prior to the expiration of the Option, the following provisions shall apply:

 

3

 

(a)           If
the Optionee is at the time of his Disability employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee for one (1) year following the
date of such Disability or until the expiration date of the Option, whichever
date is earlier, but only to the extent the Optionee was vested in and entitled
to exercise the Option at the time of his Disability.  For purposes of this Section 5, the term
“Disability” shall mean that the Optionee is unable, by reason of a medically
determinable physical or mental impairment, to substantially perform the
principal duties of employment with the Company, which condition, in the
opinion of a physician selected by the Board, is expected to have a duration of
not less than 120 days, unless the Optionee is employed by the Company, a
Parent, a Subsidiary or an Affiliate, pursuant to an employment agreement which
contains a definition of “Disability,” in which case such definition shall
control.  The Committee, in its sole
discretion, shall determine whether an Optionee has a Disability and the date of
such Disability.

 

(b)           If
the Optionee is at the time of his death employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee’s estate or by a person who
acquired the right to exercise the Option by will or the laws of descent and
distribution, for one (1) year following the date of the Optionee’s death
or until the expiration date of the Option, whichever date is earlier, but only
to the extent the Optionee was vested in and entitled to exercise the Option at
the time of death.

 

(c)           If
the Optionee is at the time of his Retirement employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee for one (1) year following the
date of the Optionee’s Retirement or until the expiration date of the Option,
whichever date is earlier, but only to the extent the Optionee was vested in
and entitled to exercise the Option at the time of Retirement.  For purposes of this Section 5,
Retirement of the Optionee shall mean, with the approval of the Committee, the
occurrence of the Optionee’s Date of Termination on or after the date the
Optionee attains age 55.

 

(d)           If
the Optionee dies within three (3) months after Termination of Optionee’s
employment with the Company or a Subsidiary the Option may be exercised for
nine (9) months following the date of Optionee’s death or the expiration
date of the Option, whichever date is earlier, by the Optionee’s estate or by a
person who acquires the right to exercise the Option by will or the laws of
descent or distribution, but only to the extent the Optionee was vested in and
entitled to exercise the Option at the time of Termination.

 

6.             Termination
of Relationship for Misconduct; Clawback. 
If the Board or the Committee reasonably believes that the Optionee has
committed an act of misconduct or breach of fiduciary duty, it may suspend the
Optionee’s right to exercise this option pending a determination by the Board
or the Committee.  If the Board or the
Committee determines that the Optionee has committed an act of  misconduct or has breached a duty to the
Company, neither the Optionee nor the Optionee’s estate shall be entitled to
exercise the Option.  For purposes of
this Section 6, an act of misconduct shall include embezzlement, fraud,
dishonesty, nonpayment of an obligation owed to the Company, breach of
fiduciary duty or deliberate disregard of the Company’s rules resulting in
loss, damage or injury to the Company, or if the Optionee makes an unauthorized
disclosure of any 

 

4

 

Company trade
secret or confidential information, engages in any conduct constituting unfair
competition with respect to the Company, or induces any party to breach a
contract with the Company.  In making
such determination, the Board or the Committee shall act fairly and shall give
the Optionee an opportunity to appear and present evidence on the Optionee’s
behalf at a hearing before the Board or the Committee.  For purposes of this Section 6, an act
of misconduct or breach of fiduciary duty to the Company shall be an event
giving the Company the right to terminate Optionee’s employment pursuant to Section         
of Optionee’s Employment Agreement with the Company dated
                              ,
which Agreement is incorporated herein by reference.  In addition, misconduct shall include willful
violations of federal or state securities laws. 
In making such determination, the Board or the Committee shall act fairly
and shall give the Optionee an opportunity to appear and present evidence on
the Optionee’s behalf at a hearing before the Board or the Committee.  In addition, if the Company, based upon an
opinion of legal counsel or a judicial determination, determines that Section 304
of the Sarbanes-Oxley Act of 2002 is applicable to Optionee hereunder, to the
extent that the Company is required to prepare an accounting restatement due to
the material noncompliance of the Company, as a result of misconduct, with any
financial reporting requirement under the securities laws, Optionee shall reimburse
the Company for any compensation received by Optionee from the Company during
the 12-month period following the first public issuance or filing with the
Securities and Exchange Commission (whichever first occurs) of the financial
document embodying such financial reporting requirement and any profits
received from the sale of the Company’s common stock or common stock
equivalents, acquired pursuant to this Agreement.

 

7.             Optionee
Bound by Plan.  The Optionee hereby
acknowledges receipt of a copy of the Plan and agrees to be bound by all the
terms and provisions thereof.  In the
event of any question or inconsistency between this Agreement and the Plan, the
terms and conditions of the Plan shall govern.

 

8.             Heirs
and Successors.  This Agreement shall
be binding upon, and inure to the benefit of, the Company and its successors
and assigns, and upon any person acquiring, whether by merger, consolidation,
purchase of assets or otherwise, all or substantially all of the Company’s
assets and business.  If any rights
exercisable by the Optionee or benefits deliverable to the Optionee under this
Agreement have not been exercised or delivered, respectively, at the time of
the Optionee’s death, such rights shall be exercisable by the Designated
Beneficiary, and such benefits shall be delivered to the Designated
Beneficiary, in accordance with the provisions of this agreement and the
Plan.  The “Designated Beneficiary” shall
be the beneficiary or beneficiaries designated by the Optionee in a writing
filed with the Committee in such form and at such time as the Committee shall
require.  If a deceased Optionee fails to
designate a beneficiary, or if the Designated Beneficiary does not survive the
Optionee, any rights that would have been exercisable by the Optionee and any
benefits distributable to the Optionee shall be exercised by or distributed to
the legal representative of the estate of the Optionee.  If a deceased Optionee designates a
beneficiary and the Designated Beneficiary survives the Optionee but dies before
the Designated Beneficiary’s exercise of all rights under this Agreement or
before the complete distribution of benefits to the Designated Beneficiary
under this Agreement, then any rights that would have been exercisable by the
Designated Beneficiary shall be exercised by the legal representative of the
estate of the Designated Beneficiary, and any benefits distributable to the
Designated Beneficiary shall be distributed to the legal representative of the
estate of the Designated Beneficiary.

 

5

 

9.             Plan
Governs.  Notwithstanding anything in
this Agreement to the contrary, the terms of this Agreement shall be subject to
the terms of the Plan, a copy of which may be obtained by the Optionee from the
office of the Secretary of the Company; and this Agreement is subject to all
interpretations, amendments, rules and regulations promulgated by the
Committee from time to time pursuant to the Plan.

 

10.           Notices.  Any notice hereunder to the Company shall be
addressed to it at its principal executive offices, located at 9725 South
Robert Trail, Inver Grove Heights, Minnesota 55077, Attention: Chief Executive
Officer; and any notice hereunder to the Optionee shall be addressed to the
Optionee at the address last appearing in the employment records of the
Company; subject to the right of either party to designate at any time
hereunder in writing some other address.

 

11.           Counterparts.  This Agreement may be executed in two
counterparts each of which shall constitute one and the same instrument.

 

12.           Governing
Law.  This Agreement shall be
governed by and construed in accordance with the laws of the State of
Minnesota, except to the extent preempted by federal law, without regard to the
principles of comity or the conflicts of law provisions of any other
jurisdiction.

 

IN WITNESS
WHEREOF, MedicalCV, Inc. has caused this Agreement to be executed by its
duly authorized officer and the Optionee has executed this Agreement, both as
of the day and year first above written.

 

	
   

  	
  MEDICALCV, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By [Name]

  
	
   

  	
  Its [Title]

  
	
   

  	
   

  
	
   

  	
  OPTIONEE

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Address:

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  

 

6

 

EXHIBIT A

 

OPTION AND VESTING DATA

 

Name of Optionee:

 

Total Number of Shares
Subject to Option:

 

Date of Grant:

 

OPTION VESTING SCHEDULE

 

	
   

  	
   

  	
  NO. OF SHARES

  	
   

  
	
  DATE

  	
   

  	
  VESTED

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  

 

The above vesting schedule assumes an ongoing
relationship with the Company.  Your
rights to exercise the unvested portion of your option will cease upon
termination of relationship with the Company, subject to Change in Control
provisions set forth in the Plan. 
Reference is made to the Plan and to relevant sections of the Agreement
between you and the Company for your rights to exercise the vested portion of
your option in the event of termination of your relationship with the Company
during lifetime or upon death.  The above
vesting schedule is in all respects subject to the terms of those documents.

 

	
  OPTIONEE

  	
   

  	
   

  	
  MEDICALCV, INC.

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
   

  	
  Its:

  	
   

  

 

 

SCHEDULE I -
NOTATIONS AS TO PARTIAL EXERCISE

 

	
   

  	
   

  	
  Number of

  	
   

  	
  Balance of

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Date of

  	
   

  	
  Purchased

  	
   

  	
  Shares on

  	
   

  	
  Authorized

  	
   

  	
  Notation

  	
   

  
	
  Exercise

  	
   

  	
  Shares

  	
   

  	
  Option

  	
   

  	
  Signature

  	
   

  	
  Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00136-of-00352.parquet"}]]